Comparing Blincyto vs Mercaptopurine
| Blincyto (blinatumomab) | Mercaptopurine |
|
|---|
| Blincyto (blinatumomab) | Mercaptopurine |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Acute Lymphoblastic Leukemia. Blincyto may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Autoimmune Hepatitis, Crohn's Disease - Maintenance, Acute Lymphoblastic Leukemia, Crohn's Disease - Active, Inflammatory Bowel Disease, Intestinal Arterial Insufficiency, Ulcerative... View more |
Related suggestions Acute Lymphoblastic Leukemia
|
|||||||||||||||
| More about Blincyto (blinatumomab) | More about Mercaptopurine | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Blincyto has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Mercaptopurine has an average rating of 6.2 out of 10 from a total of 32 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 31% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Blincyto side effects |
View all Mercaptopurine side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
Lower cost generic |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Blincyto prices |
View all Mercaptopurine prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
Purinethol, Purixan | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
2.11 hours |
2 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 278 drugs are known to interact with Blincyto:
|
A total of 303 drugs are known to interact with Mercaptopurine:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
December 03, 2014 |
September 11, 1953 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.